Loading…
Solvias
Partnering with life science innovators to achieve commercialization goals
About
Solvias is a cGMP contract research organization headquartered in Kaiseraugst, Switzerland, offering analytical services for small molecule APIs, biologics and cell & gene therapies. Its stated service lines are analytical method development and validation, analytical characterization, cGMP drug substance and drug product testing and release, excipient and raw material testing, genetic quality control testing, extractables & leachables, stability testing, biosafety testing, impurity testing and contamination control, and container closure integrity testing. The company states it was founded in 1999 after being part of Novartis and reports 800+ team members in Europe and the U.S., 175+ PhD-level scientists and 700+ customers worldwide.
Deterministic scores · rules-based, not AIiHow these scores are obtained: each one is computed from this profile's listed attributes — capability checkboxes, certifications, capacity figures and coverage — by a fixed formula, recomputed on every page load. Deterministic and rules-based means the score comes from a fixed, transparent formula over listed attributes — the same inputs always produce the same score. It is not AI: there is no model, no learning, and no hidden weighting. Whether a score is relevant to you depends on your specific project: a capability that raises the number may not matter for your work, and a niche strength your project needs may barely move it. Capability scores are a directional starting point, not a verdict. A lower score does not disqualify a company or consultant, and no decision should rest on the score alone — always contact the company directly to confirm the specifics for your project.
Lab capability iCounts what the profile lists across three areas: service categories add 2.5 points each (capped at 40), analytical platforms (bioanalytical, genomics, immunogenicity, and cell-and-gene-therapy assays combined) add 2 points each (capped at 30), and therapeutic areas add 3 points each (capped at 30). Levels: 80+ Comprehensive lab | 60-79 Broad capability | 40-59 Established | below 40 Emerging. Whether this dimension matters for you depends on your specific project.
0Emerging
Accreditation iAdds fixed points for each accreditation held: CAP 20, ISO 15189 14, CLIA 12, GCLP 12, ISO 17025 10, GLP 10, GMP 8. Inspection history adds more: 4 points per listed authority (up to 14) with a no-findings outcome, 3 per authority (up to 8) with minor findings, or 4 flat when authorities are listed without an adverse (OAI or VAI) outcome. Levels: 80+ Fully accredited | 60-79 Strong | 40-59 Established | below 40 Developing. Whether this dimension matters for you depends on your specific project.
18Developing
Scientific depth iAdds fixed points for each scientific capability the profile checks: genomics sequencing 18, cell-and-gene-therapy testing 18, immunogenicity testing 16, bioanalysis 16, biomarker testing 16, companion diagnostics 8, and flow cytometry 8. Levels: 80+ Cutting-edge | 60-79 Advanced | 40-59 Developing | below 40 Foundational. Whether this dimension matters for you depends on your specific project.
44Developing
Logistics reach iRegions supported add 7 points each, capped at 45, plus fixed points for shipping capabilities: cold chain 12, cryogenic transport 12, customs expertise 10, and 7 each for dry ice, sample collection kits, and ambient transport. Levels: 80+ Global reach | 60-79 Multi-region | 40-59 Regional | below 40 Limited. Whether this dimension matters for you depends on your specific project.
0Limited
Quality iBuilt from reported metrics: on-time delivery rate contributes up to 35 points (0.35 per percent), average turnaround earns 25 at 3 days or less, 18 at up to 7, 10 at up to 14, else 3; deviation and repeat-testing rates each start at 20 and lose 2 points per percentage point. Shows Not reported (score 0) when neither on-time delivery nor turnaround is provided. Levels: 80+ Exceptional | 60-79 Strong | 40-59 Solid | below 40 Developing. Whether this dimension matters for you depends on your specific project.
0Not reported
Trial readiness iEach supported trial phase (1 through 4) adds 9 points (max 36), therapeutic areas add 2.5 each (capped at 24), and completed studies add 1 point per 20 studies (capped at 20), plus 10 each for GCLP and GMP compliance. Levels: 80+ Trial-ready | 60-79 Strong | 40-59 Established | below 40 Emerging. Whether this dimension matters for you depends on your specific project.
10Emerging
Testing capabilities
Genomics & sequencingCell & gene therapyFlow cytometry
Live record · illustrative seed data · scores deterministic, rules-based — not AI.